ICU Medical, Inc.

NMS: ICUI
Live Quote

📈 ZcoreAI Score

Our AI model analyzes ICU Medical, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get ICUI Z-Score →

About ICU Medical, Inc.

Healthcare Medical Instruments & Supplies
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

📊 Fundamental Analysis

ICU Medical, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.

The company recently reported -14.1% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is 0.0%, which suggests room for improvement in capital utilization.

At a current price of $125.68, ICUI currently sits at the 35th percentile of its 52-week range (Range: $107.00 - $160.29).

💰 Valuation Insight

ICUI trades at a 16657.3% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$3.14B
Trailing P/E
4189.33
Forward P/E
13.66
Beta (5Y)
0.85
52W High
$160.29
52W Low
$107.00
Avg Volume
288K
Day High
Day Low
Get ICUI Z-Score on Dashboard 🚀